| Old Articles: <Older 1341-1350 Newer> |
 |
The Motley Fool August 2, 2004 Brian Gorman |
Will Lipitor's Certification Boost Pfizer? The FDA's ruling may help the company ward off a new threat.  |
The Motley Fool August 2, 2004 Charly Travers |
What's a Drug Worth? The value of small biotech companies is in their investigational drug programs.  |
The Motley Fool July 30, 2004 J. Graham |
Biolase by the Numbers The dental laser company is trying to shore up investor confidence by declaring a dividend and shaking up management, but their poor numbers, among other problems, keep it from being a good buy for now.  |
The Motley Fool July 30, 2004 Roger Nusbaum |
Gilead Keeps Rolling Along Biotech can be a tough place to invest, but Gilead Sciences offers relative stability.  |
The Motley Fool July 30, 2004 W.D. Crotty |
This Nanotech Deserves Respect While the stock recently hit some potholes, Flamel still looks good for the future.  |
Managed Care July 2004 John Carroll |
The Weight Debate Encouraged by employers, health plans ponder expensive options in covering a generation of obese Americans.  |
Managed Care July 2004 Maureen Glabman |
Wish List: 10 Things You Want From Your PBM One auditor estimates that 3 percent to 10 percent of pharmacy benefit manager (PBM) claims are processed incorrectly -- always in favor of the PBM.  |
BusinessWeek August 9, 2004 Gene G. Marcial |
MGI Pharma Has Just What Patients Need Its first major drug, an injection to prevent chemotherapy-induced nausea and vomiting, is on fire in a $1.5 billion market. And turning MGI into a moneymaker.  |
The Motley Fool July 29, 2004 Brian Gorman |
Bristol-Myers Bottoming Out? The pharmaceutical company's expectations are in doubt, but investors might want to focus on its potential.  |
The Motley Fool July 29, 2004 Rich Duprey |
Dentsply Makes Investors Smile The dental-supply company continues reporting solid profit and earnings growth. Dentsply looks as though it will continue to be a steady, consistent performer.  |
| <Older 1341-1350 Newer> Return to current articles. |